XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Revenue:    
Total revenue $ 1,649,230 $ 1,361,340
Cost of revenue:    
Amortization of acquired intangible assets 20,456 18,640
Total cost of revenue 329,175 284,354
Gross margin 1,320,055 1,076,986
Operating expenses:    
Research and development 552,056 465,329
Sales and marketing 263,408 210,785
General and administrative 138,374 97,364
Amortization of acquired intangible assets 6,597 6,717
Restructuring charges 0 40,859
Total operating expenses 960,435 821,054
Operating income 359,620 255,932
Interest and other income (expense), net 105,484 23,292
Income before income taxes 465,104 279,224
Provision (benefit) for income taxes 18,897 10,597
Net income 446,207 268,627
Net income (loss) attributed to non-controlling interest and redeemable non-controlling interest (2,905) (2,909)
Net income attributed to Synopsys $ 449,112 $ 271,536
Net income per share attributed to Synopsys:    
Basic (in USD per share) $ 2.95 $ 1.78
Diluted (in USD per share) $ 2.89 $ 1.75
Shares used in computing per share amounts:    
Basic (shares) 152,311 152,401
Diluted (shares) 155,334 155,076
Product    
Revenue:    
Total revenue $ 1,352,241 $ 1,118,971
Cost of revenue:    
Cost of revenue 193,638 174,367
Time-based products    
Revenue:    
Total revenue 904,378 782,313
Upfront products    
Revenue:    
Total revenue 447,863 336,658
Maintenance and service    
Revenue:    
Total revenue 296,989 242,369
Cost of revenue:    
Cost of revenue $ 115,081 $ 91,347